Zakynthos Informer Zakynthos Informer
Related Articles
One of the 18 research projects recently selected for funding of € 48.2 million from the European Union’s Horizon 2020 program , aimed at developing diagnostic and therapeutic tools to combat coronary pandemics, is already yielding positive results.
Researchers at the HG nCoV19 test have approved the introduction of a new point-of-care test for Covid-19 disease.
The HG nCoV19 test involves public and private entities from Ireland, Italy, the United Kingdom and China, which have developed a new portable diagnostic system for the detection of viral infections, which gives accurate and reliable results within 30 minutes.
The Dublin-based Irish company HiberGene, which coordinates the project, said it had received the CE marking required to market medical devices.
The test can give results on samples with moderate to high viral loads, allowing the rapid diagnosis of the infection in the initial and highly infectious stage .
The EU has been supporting HiberGene since the end of July 2000, with support for the project amounting to 930,000 euros. As of January 2020, € 474 million has already been mobilized under the “Horizons 2020” program to address the coronavirus disease.
source:-https://www.euro2day.gr/
